Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms
2020-003739-62Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cannabidiol in post-traumatic stress disorder (PTSD) and anxiety disorder, sponsored by University Medical Center Utrecht. Started Apr 2021; status: active.
02
Drugs
cannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disorder
Beyond the preview
Go deeper on 2020-003739-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003739-62.